Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese.

Source:http://linkedlifedata.com/resource/pubmed/id/11238525

Download in:

View as

General Info

PMID
11238525